Sarepta Therapeutics (SRPT) Interest Coverage Ratio (2017 - 2022)
Sarepta Therapeutics (SRPT) recorded quarterly Interest Coverage Ratio of 8.41 in Q4 2022, up 5.63% quarter-over-quarter from 8.91 in Q3 2022, and down 27.58% on a YoY basis from 11.62 in Q4 2021.
Sarepta Therapeutics (SRPT) Interest Coverage Ratio (2017 - 2022) Analysis & Trends
Sarepta Therapeutics' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 8.41 for Q4 2022.
- In Q4 2022, Interest Coverage Ratio fell 27.58% year-over-year to 8.41; the TTM figure through Sep 2023 stood at 31.44 (down 273.28% YoY), while the FY2023 annual figure was 12.17, down 20.84% from the prior year.
- Interest Coverage Ratio was 8.41 for Q4 2022 at Sarepta Therapeutics, up from 8.91 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.67 in Q3 2021 to a low of 444.11 in Q1 2019.
- Historically, Interest Coverage Ratio has averaged 52.16 across 5 years, with a median of 10.21 in 2018.
- The sharpest annual moves came in 2019 and 2020: Interest Coverage Ratio plunged 10929.44% in 2019, then jumped 98.05% in 2020.
- A 5-year view of Interest Coverage Ratio shows it stood at 60.3 in 2018, then jumped by 54.5% to 27.44 in 2019, then jumped by 42.15% to 15.87 in 2020, then soared by 58.47% to 6.59 in 2021, then dropped by 27.58% to 8.41 in 2022.
- The last three Interest Coverage Ratio figures came in at 8.41 (Q4 2022), 8.91 (Q3 2022), and 12.45 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -8.41 |
| Sep 30, 2022 | -8.91 |
| Jun 30, 2022 | -12.45 |
| Mar 31, 2022 | -5.50 |
| Dec 31, 2021 | -6.59 |
| Sep 30, 2021 | -1.67 |
| Jun 30, 2021 | -10.35 |
| Mar 31, 2021 | -9.70 |
| Dec 31, 2020 | -15.87 |
| Sep 30, 2020 | -9.56 |
| Jun 30, 2020 | -11.12 |
| Mar 31, 2020 | -8.67 |
| Dec 31, 2019 | -27.44 |
| Sep 30, 2019 | -49.24 |
| Jun 30, 2019 | -319.45 |
| Mar 31, 2019 | -444.11 |
| Dec 31, 2018 | -60.30 |
| Sep 30, 2018 | -10.06 |
| Jun 30, 2018 | -19.82 |
| Mar 31, 2018 | -4.03 |